Compare NRIX & INOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NRIX | INOD |
|---|---|---|
| Founded | 2009 | 1988 |
| Country | United States | United States |
| Employees | N/A | 3000 |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.4B |
| IPO Year | 2020 | 1996 |
| Metric | NRIX | INOD |
|---|---|---|
| Price | $23.19 | $62.45 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 2 |
| Target Price | $30.50 | ★ $100.00 |
| AVG Volume (30 Days) | ★ 1.9M | 1.2M |
| Earning Date | 04-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.37 |
| EPS | N/A | ★ 0.42 |
| Revenue | $76,987,000.00 | ★ $86,775,000.00 |
| Revenue This Year | N/A | $38.42 |
| Revenue Next Year | $48.05 | $27.03 |
| P/E Ratio | ★ N/A | $144.64 |
| Revenue Growth | ★ 99.31 | 9.84 |
| 52 Week Low | $8.20 | $34.23 |
| 52 Week High | $25.09 | $125.14 |
| Indicator | NRIX | INOD |
|---|---|---|
| Relative Strength Index (RSI) | 61.64 | 33.03 |
| Support Level | $14.63 | $40.89 |
| Resistance Level | $24.98 | $64.25 |
| Average True Range (ATR) | 1.25 | 4.59 |
| MACD | -0.23 | -1.08 |
| Stochastic Oscillator | 50.58 | 20.62 |
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.
Innodata Inc is a data engineering company. It is helping companies deploy and integrate AI into their operations and products and providing AI-enabled industry platforms. The Company's operations are classified in three reporting segments: Digital Data Solutions (DDS), Synodex and Agility. Key revenue is generated from DDS segment provides AI data preparation services, collecting or creating training data, annotating training data, and training AI algorithms for its customers, and AI model deployment and integration. It also provides a range of data engineering support services including data transformation, data curation, data hygiene, data consolidation, data extraction, data compliance, and master data management.